Eli Lilly to invest $6 billion in Alabama plant for obesity pill and other drug production
Eli Lilly announced it will invest $6 billion to build a new manufacturing plant in Huntsville, Alabama, aimed at increasing production of its experimental obesity pill, orforglipron, as well as…